Presentations

30+ talks from R/Pharma 2025 across 8 thematic sessions

Overview

The R/Pharma 2025 conference featured over 30 presentations organized into 8 Europe/US thematic sessions and an Asia/Pacific session. These talks covered the latest innovations, case studies, and strategic insights in using R for pharmaceutical research and development.

📍 Browse by Region

🌍 Europe/US Sessions

8 thematic sessions covering:

🤖 Practical AI for data science
📊 Advanced analytics and tools
🏢 Enterprise transformations
✅ Validation approaches
🚀 Innovation case studies

Featured presentations:

GSK’s Journey to Open Source
Mosaic: ARS-Driven TFL Automation
{llumen}: Agentic LLM Framework
GenAI in Production

Explore Europe/US sessions →

🌏 Asia/Pacific Presentations

13 presentations featuring:

🏛️ Open-source culture and strategy
⚙️ Automation and efficiency tools
🤖 AI and LLM implementations
📋 Regulatory compliance (PMDA)
🔬 Specialized applications

Highlights:

SHIONOGI’s Open-Source Strategy
{meRlin}: AI Assistant for Clinical Programming
Dynamic K-M Plots with Shiny
PMDA e-CRT Creation

Explore Asia/Pacific presentations →

🔥 Top Themes

🤖 AI & LLM Integration

8+ presentations on artificial intelligence:

Practical AI for secure deployments
Agentic frameworks ({llumen}, {mcpr})
LLM-powered clinical data review
Multi-agent R copilots
AI assistants for programming

📊 Clinical Reporting Automation

10+ presentations on streamlining TFLs and reports:

ARS-driven automation (Mosaic)
{crane} extending {gtsummary}
autoslideR for slide generation
Template-based DMC materials
Interactive Shiny applications

✅ Validation & Compliance

6+ presentations on GxP and regulatory topics:

Shiny apps in regulated environments
R library validation with ATDD
Risk assessment frameworks
Code review best practices
Metric repositories for quality assessment

🚀 Enterprise Adoption

5+ presentations on organizational transformation:

GSK’s 50%+ open-source journey
Beyond training: R support models
SAS to R migration strategies
Pfizer’s RWD programming infrastructure
Collaborative programming with traceability

📈 Advanced Methods

8+ presentations on statistical and ML approaches:

Bayesian exposure-response analysis
TabPFN for tabular data
Synthetic data generation
NCA software implementation
Survival analysis automation

📊 Session Breakdown

Europe/US Sessions

Session 1: Practical AI & Industry Adoption

Practical AI for Data Science (Posit)
duckplyr: DuckDB with dplyr (Cynkra)
Beyond Training: R Adoption (GSK)
Validating Shiny Apps (Jumping Rivers)
Beyond {gtsummary}: {crane} (Genentech)

Session 2: Advanced AI Systems

{llumen}: Agentic Framework (Merck KGaA)
MCP Servers in R (Opifex)

Session 3: Automation & Innovation

Mosaic: ARS-Driven TFLs (Novartis)
Collaborative Programming (Graticule)

Session 4: Machine Learning & Tools

TabPFN for Tabular Data (Posit)
LLM Lounge with Databot (Posit)
LLM-Powered {gtsummary} (Roche)
Post-Approval Exposure (AstraZeneca)
End-to-End NCA (Lucid Analytics)
{admiral}’s Journey (Roche)

Session 5: Enterprise Transformation

GSK’s Open Source Journey (GSK)

Session 6: AI Integration Case Studies

ellmer + GPT in Shiny (Moderna)
autoslideR (Roche)
R in RWD (Pfizer)
Synthetic Data (Abbott)

Session 7: Advanced Innovation

GenAI in Production (A2-AI)
Ultimate R AI Assistant (Roche)
Dependency Whisperer (Eli Lilly)
BayesERtools (Genentech)

Session 8: Regulatory & Methods

Covariate Adjustment (Novartis)
R Library Validation (ex-Novartis)

Asia/Pacific Session

13 presentations covering strategic initiatives, automation tools, AI implementations, and regional regulatory requirements (especially PMDA).

🏢 Organizations Represented

Major pharmaceutical companies and organizations presenting:

Posit (6+ presentations)
Roche/Genentech (5+ presentations)
GSK (2 presentations)
Novartis (2 presentations)
Eli Lilly (2 presentations)
Pfizer (1 presentation)
Moderna (1 presentation)
AstraZeneca (1 presentation)
Merck KGaA (1 presentation)
Abbott (1 presentation)
SHIONOGI (1 presentation)
A2-AI (1 presentation)
Jumping Rivers (1 presentation)
Cynkra (1 presentation)
Opifex (1 presentation)
Lucid Analytics (1 presentation)
Graticule (1 presentation)
CIMS Global (2 presentations)
Amaris Consulting (1 presentation)

🎯 Quick Links by Topic

Looking for specific topics?

AI & LLM

Clinical Reporting

Validation

Enterprise Adoption

📈 Presentation Statistics

30+

Total Presentations

EU/US Sessions

Asia/Pacific

20+

Organizations

💡 Key Takeaways

Industry Transformation

GSK leading with 50%+ R code target achieved
Major pharma embracing open-source workflows
SAS to R migration gaining momentum

AI Revolution

Practical, production-ready implementations
Privacy-preserving approaches for clinical data
Agentic systems and tool orchestration

Standards Adoption

CDISC ARS/ARM driving automation
Harmonized outputs across organizations
Machine-readable analysis results

Validation Maturity

Risk-based approaches becoming standard
Shared metric repositories emerging
GxP-ready Shiny applications feasible

Want More Details?

Most presentations include links to GitHub repositories, slides, or additional resources. Check the individual session pages for:

📎 Links to materials
🔗 GitHub repositories
📊 Presentation slides
📧 Speaker contact information

All presentations from R/Pharma 2025 Conference | Last updated: November 2025

--- title: "Presentations" subtitle: "30+ talks from R/Pharma 2025 across 8 thematic sessions" toc: false --- ## Overview The R/Pharma 2025 conference featured over 30 presentations organized into 8 Europe/US thematic sessions and an Asia/Pacific session. These talks covered the latest innovations, case studies, and strategic insights in using R for pharmaceutical research and development. ------------------------------------------------------------------------ ## 📍 Browse by Region ::::: columns ::: {.column width="48%"} ### [🌍 Europe/US Sessions](europe-us-sessions.qmd) {.presentation-card} **8 thematic sessions** covering: - 🤖 Practical AI for data science - 📊 Advanced analytics and tools - 🏢 Enterprise transformations - ✅ Validation approaches - 🚀 Innovation case studies **Featured presentations:** - GSK's Journey to Open Source - Mosaic: ARS-Driven TFL Automation - {llumen}: Agentic LLM Framework - GenAI in Production [Explore Europe/US sessions →](europe-us-sessions.qmd) ::: ::: {.column width="48%"} ### [🌏 Asia/Pacific Presentations](asia-pacific-sessions.qmd) {.presentation-card} **13 presentations** featuring: - 🏛️ Open-source culture and strategy - ⚙️ Automation and efficiency tools - 🤖 AI and LLM implementations - 📋 Regulatory compliance (PMDA) - 🔬 Specialized applications **Highlights:** - SHIONOGI's Open-Source Strategy - {meRlin}: AI Assistant for Clinical Programming - Dynamic K-M Plots with Shiny - PMDA e-CRT Creation [Explore Asia/Pacific presentations →](asia-pacific-sessions.qmd) ::: ::::: ------------------------------------------------------------------------ ## 🔥 Top Themes ### 🤖 AI & LLM Integration **8+ presentations** on artificial intelligence: - Practical AI for secure deployments - Agentic frameworks ({llumen}, {mcpr}) - LLM-powered clinical data review - Multi-agent R copilots - AI assistants for programming ### 📊 Clinical Reporting Automation **10+ presentations** on streamlining TFLs and reports: - ARS-driven automation (Mosaic) - {crane} extending {gtsummary} - autoslideR for slide generation - Template-based DMC materials - Interactive Shiny applications ### ✅ Validation & Compliance **6+ presentations** on GxP and regulatory topics: - Shiny apps in regulated environments - R library validation with ATDD - Risk assessment frameworks - Code review best practices - Metric repositories for quality assessment ### 🚀 Enterprise Adoption **5+ presentations** on organizational transformation: - GSK's 50%+ open-source journey - Beyond training: R support models - SAS to R migration strategies - Pfizer's RWD programming infrastructure - Collaborative programming with traceability ### 📈 Advanced Methods **8+ presentations** on statistical and ML approaches: - Bayesian exposure-response analysis - TabPFN for tabular data - Synthetic data generation - NCA software implementation - Survival analysis automation ------------------------------------------------------------------------ ## 📊 Session Breakdown ### Europe/US Sessions ::: timeline-item **Session 1: Practical AI & Industry Adoption** - Practical AI for Data Science (Posit) - duckplyr: DuckDB with dplyr (Cynkra) - Beyond Training: R Adoption (GSK) - Validating Shiny Apps (Jumping Rivers) - Beyond {gtsummary}: {crane} (Genentech) ::: ::: timeline-item **Session 2: Advanced AI Systems** - {llumen}: Agentic Framework (Merck KGaA) - MCP Servers in R (Opifex) ::: ::: timeline-item **Session 3: Automation & Innovation** - Mosaic: ARS-Driven TFLs (Novartis) - Collaborative Programming (Graticule) ::: ::: timeline-item **Session 4: Machine Learning & Tools** - TabPFN for Tabular Data (Posit) - LLM Lounge with Databot (Posit) - LLM-Powered {gtsummary} (Roche) - Post-Approval Exposure (AstraZeneca) - End-to-End NCA (Lucid Analytics) - {admiral}'s Journey (Roche) ::: ::: timeline-item **Session 5: Enterprise Transformation** - GSK's Open Source Journey (GSK) ::: ::: timeline-item **Session 6: AI Integration Case Studies** - ellmer + GPT in Shiny (Moderna) - autoslideR (Roche) - R in RWD (Pfizer) - Synthetic Data (Abbott) ::: ::: timeline-item **Session 7: Advanced Innovation** - GenAI in Production (A2-AI) - Ultimate R AI Assistant (Roche) - Dependency Whisperer (Eli Lilly) - BayesERtools (Genentech) ::: ::: timeline-item **Session 8: Regulatory & Methods** - Covariate Adjustment (Novartis) - R Library Validation (ex-Novartis) ::: ### Asia/Pacific Session 13 presentations covering strategic initiatives, automation tools, AI implementations, and regional regulatory requirements (especially PMDA). ------------------------------------------------------------------------ ## 🏢 Organizations Represented Major pharmaceutical companies and organizations presenting: ::: {layout-ncol="3"} - **Posit** (6+ presentations) - **Roche/Genentech** (5+ presentations) - **GSK** (2 presentations) - **Novartis** (2 presentations) - **Eli Lilly** (2 presentations) - **Pfizer** (1 presentation) - **Moderna** (1 presentation) - **AstraZeneca** (1 presentation) - **Merck KGaA** (1 presentation) - **Abbott** (1 presentation) - **SHIONOGI** (1 presentation) - **A2-AI** (1 presentation) - **Jumping Rivers** (1 presentation) - **Cynkra** (1 presentation) - **Opifex** (1 presentation) - **Lucid Analytics** (1 presentation) - **Graticule** (1 presentation) - **CIMS Global** (2 presentations) - **Amaris Consulting** (1 presentation) ::: ------------------------------------------------------------------------ ## 🎯 Quick Links by Topic **Looking for specific topics?** ### AI & LLM - [Practical AI for Data Science](europe-us-sessions.qmd#practical-ai-for-data-science) - [{llumen}: Agentic Framework](europe-us-sessions.qmd#llumen-agentic-llm-framework-for-biomedical-documents) - [LLM-Powered {gtsummary}](europe-us-sessions.qmd#llm-powered-gtsummary-qc-ready-tables) - [GenAI in Production](europe-us-sessions.qmd#genai-in-production) - [Ultimate R AI Assistant](europe-us-sessions.qmd#building-the-ultimate-r-ai-assistant) ### Clinical Reporting - [Mosaic: ARS-Driven Automation](europe-us-sessions.qmd#mosaic-ars-driven-automation-of-standard-tfls) - [Beyond {gtsummary}: {crane}](europe-us-sessions.qmd#beyond-gtsummary-the-crane-package) - [autoslideR](europe-us-sessions.qmd#autoslider-streamlining-slide-deck-generation) - [officer/flextable workshop details](../workshops/clinical-reporting/officer-flextable.qmd) ### Validation - [Validating Shiny Apps](europe-us-sessions.qmd#validating-shiny-apps-in-regulated-environments) - [R Library Validation ATDD](europe-us-sessions.qmd#r-library-validation-using-atdd) - [Risk Assessment Deep Dive](asia-pacific-sessions.qmd#risk-assessment-deep-dive) ### Enterprise Adoption - [GSK's Open Source Journey](europe-us-sessions.qmd#gsks-journey-to-clinical-study-reporting-using-open-source) - [Beyond Training at GSK](europe-us-sessions.qmd#beyond-training-teaching-r-adoption-at-gsk) - [Pfizer R in RWD](europe-us-sessions.qmd#putting-the-r-in-rwd) ------------------------------------------------------------------------ ## 📈 Presentation Statistics ::::::: {layout-ncol="4"} ::: stats-box **30+** Total Presentations ::: ::: stats-box **8** EU/US Sessions ::: ::: stats-box **13** Asia/Pacific ::: ::: stats-box **20+** Organizations ::: ::::::: ------------------------------------------------------------------------ ## 💡 Key Takeaways ### Industry Transformation - GSK leading with **50%+ R code** target achieved - Major pharma embracing open-source workflows - SAS to R migration gaining momentum ### AI Revolution - Practical, production-ready implementations - Privacy-preserving approaches for clinical data - Agentic systems and tool orchestration ### Standards Adoption - CDISC ARS/ARM driving automation - Harmonized outputs across organizations - Machine-readable analysis results ### Validation Maturity - Risk-based approaches becoming standard - Shared metric repositories emerging - GxP-ready Shiny applications feasible ------------------------------------------------------------------------ ::: callout-tip ## Want More Details? Most presentations include links to GitHub repositories, slides, or additional resources. Check the individual session pages for: - 📎 Links to materials - 🔗 GitHub repositories - 📊 Presentation slides - 📧 Speaker contact information ::: ------------------------------------------------------------------------ *All presentations from R/Pharma 2025 Conference \| Last updated: November 2025*